Previous close | 1.7300 |
Open | 1.8100 |
Bid | 1.7000 x 1100 |
Ask | 1.8100 x 1000 |
Day's range | 1.7100 - 1.8100 |
52-week range | 1.6800 - 4.0000 |
Volume | |
Avg. volume | 25,560 |
Market cap | 91.769M |
Beta (5Y monthly) | 0.38 |
PE ratio (TTM) | 3.78 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 27 Mar 2024 |
1y target est | N/A |
iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced that it filed its annual report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission on April 25, 2024. The annual report on Form 20-F is available on the Company's investor relations website at https://ir.ihuman.com/. iHuman will provide a hard copy of its annual report on Form 20-F containing complete a
iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023.
iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today published its first environmental, social and governance (ESG) report, covering its ESG activities in 2022. The report provides comprehensive information on the Company's ESG governance mechanisms and details its performance across a range of environmental and social indicators.